Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, California, USA.
Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.
Am J Gastroenterol. 2020 Jul;115(7):1129-1132. doi: 10.14309/ajg.0000000000000712.
High rates of concurrent gastrointestinal manifestations have been noted in patients with corona virus disease 2019 (COVID-19); however, the association between these digestive manifestations and need for hospitalization has not been established.
This is a retrospective review of consecutive patients diagnosed with COVID-19. A total of 207 patients were identified; 34.5% of patients noted concurrent gastrointestinal symptoms, with 90% of gastrointestinal symptoms being mild.
In a multivariate regression model controlled for demographics and disease severity, an increased risk of hospitalization was noted in patients with any digestive symptom (adjusted odds ratio 4.84, 95% confidence interval: 1.68-13.94).
The presence of digestive symptoms in COVID-19 is associated with a need for hospitalization.
新型冠状病毒病 2019（COVID-19）患者常伴有胃肠道表现；然而，这些消化系统表现与住院需求之间的关系尚未确定。
这是一项对连续确诊 COVID-19 患者的回顾性研究。共确定了 207 例患者；34.5%的患者存在胃肠道症状，90%的胃肠道症状为轻度。
在调整了人口统计学和疾病严重程度的多变量回归模型中，存在任何消化系统症状的患者住院风险增加（调整后的优势比 4.84，95%置信区间：1.68-13.94）。
COVID-19 患者存在消化系统症状与住院需求相关。
